HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by WEISS, R. R. Articles by WALDMAN, T. A. Search for Related Content PubMed PubMed Citation Articles by WEISS, R. R. Articles by WALDMAN, T. A.

Amniotic Fluid -Fetoprotein as a Marker in Prenatal Diagnosis of Neural Tube Defects

Departments of Obstetrics and Gynecology and Animal Research at the Nassau County Medical Center. East Meadow. New York, and the Laboratory of Cell Biology and Metabolism Branch. National Cancer Institute, NIH, Bethesda, Maryland.

The prenatal diagnosis of anencephaly and spina bifida (neural tube defect. NTD) through amniotic fluid analysis for -fetoprotein (AFP) is gradually gaining clinical recognition. AFP concentration); were determined in 237 amniotic fluids from normal pregnancies ranging between 7 and 42 weeks of gestation. A steady decline in AFP from 26 µ/ml at 7–9 weeks to 155ng/ml at term is observed. AFP concentration was determined in 35 amniotic fluids from 33 confirmed neural tube defective pregnancies. In 14 cases where amniotic fluid was examined prior to the 26th week of gestation. AFP was markedly elevated when compared with the normal range of the same gestational period. In 21 amniotic fluids past the 26th week, 17 cases (85) had markedly elevated AFP levels; however, 2 cases of anencephaly, 1 of spina bifida, and I of hydrocephaly gave levels within the normal range. It is concluded that elevated AFP in the amniotic fluid is a reliable but nonspecific marker for open neural tube defects prior to the 26th week of pregnancy, but may become normal after the 26th week in a small percentage of patients.